Genflow Biosciences plc (LON:GENF – Get Free Report) traded down 11.7% during trading on Tuesday . The stock traded as low as GBX 1.70 and last traded at GBX 1.70. 1,475,341 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 958,797 shares. The stock had previously closed at GBX 1.93.
Genflow Biosciences Trading Down 11.7%
The firm has a fifty day simple moving average of GBX 1.87 and a two-hundred day simple moving average of GBX 1.33. The firm has a market cap of £8.39 million, a PE ratio of -3.39 and a beta of 2.37.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
- Five stocks we like better than Genflow Biosciences
- A month before the crash
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
